Ondine Biomedical IncLSE Ondine Stock Report

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-12-06. The firm is engaged in the development and commercialization of anti-infective therapies covering a various bacterial, fungal and viral infections primarily using antimicrobial photodynamic therapy (aPDT) as a platform technology for its products, which are used as an alternative to the use of antibiotics. The Company’s aPDT products uses laser-based activation of compounds to treat a range of medical infections. Its Photodisinfection platform, is a light-based antimicrobial technology that provides rapid destruction of a range of pathogens without causing antibiotic resistance. The firm offers Steriwave product, which is a photodisinfection-based medical device to eliminate harmful nasal pathogens that can lead to healthcare-associated infections (HAIs).